^
    CANCER:

    Prolymphocytic Leukemia





    Show legend
    Group by Gene:
    0
    CD52 inhibitor
    alemtuzumab
    1
    Adenosine deaminase inhibitor
    pentostatin
    2
    BRAF inhibitor, BRAF V600E inhibitor
    vemurafenib
    3
    JAK1 inhibitor, JAK2 inhibitor
    ruxolitinib
    4
    JAK1 inhibitor, JAK2 inhibitor, Bcl2 inhibitor
    venetoclax + ruxolitinib
    5
    BTK inhibitor
    ibrutinib
    6
    Bcr-abl tyrosine kinase inhibitor, Src kinase inhibitor, c-KIT inhibitor, PDGFR β antagonist, EphA2 receptor antagonist
    dasatinib
    7
    Bcl2 inhibitor
    venetoclax
    No biomarker
    CD52 expression
    BRAF V600E
    JAK3 mutation
    RAD50 Y625
    ATM D2721N
    PAK4 deletion
    NOTCH1 mutation
    CDKN2A deletion
    STAT5B N642H
    TCL1A rearrangement